Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib

Matthew D. Hellmann; Boris Reva; Helena Yu; Valerie W. Rusch; Naiyer A. Rizvi; Mark G. Kris; Maria E. Arcila

doi:10.1097/JTO.0000000000000221

Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib

Matthew D. Hellmann
, Boris Reva
, Helena Yu
, Valerie W. Rusch
, Naiyer A. Rizvi
, Mark G. Kris
, Maria E. Arcila

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Original language	English
Pages (from-to)	e73-e74
Journal	Journal of Thoracic Oncology
Volume	9
Issue number	10
DOIs	https://doi.org/10.1097/JTO.0000000000000221
State	Published - 1 Oct 2014
Externally published	Yes

Access to Document

10.1097/JTO.0000000000000221

Cite this

@article{fb7ac634ca864c758e36b6ce128a121a,

title = "Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib",

author = "Hellmann, \{Matthew D.\} and Boris Reva and Helena Yu and Rusch, \{Valerie W.\} and Rizvi, \{Naiyer A.\} and Kris, \{Mark G.\} and Arcila, \{Maria E.\}",

year = "2014",

month = oct,

day = "1",

doi = "10.1097/JTO.0000000000000221",

language = "English",

volume = "9",

pages = "e73--e74",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "10",

}

TY - JOUR

T1 - Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib

AU - Hellmann, Matthew D.

AU - Reva, Boris

AU - Yu, Helena

AU - Rusch, Valerie W.

AU - Rizvi, Naiyer A.

AU - Kris, Mark G.

AU - Arcila, Maria E.

PY - 2014/10/1

Y1 - 2014/10/1

UR - https://www.scopus.com/pages/publications/84925813420

U2 - 10.1097/JTO.0000000000000221

DO - 10.1097/JTO.0000000000000221

M3 - Article

C2 - 25521405

AN - SCOPUS:84925813420

SN - 1556-0864

VL - 9

SP - e73-e74

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 10

ER -